ContributorsPublishersAdvertisers

EC-18 Reduces Duration and Incidence of Chemoradiation-Induced Oral Mucositis in Head and Neck Cancer

onclive.com
 2021-10-21

Treatment with the small molecule oral immunomodulator EC-18 resulted in a reduction in both the duration and incidence of severe oral mucositis in patients with head and neck cancer who are undergoing concurrent chemoradiation. Treatment with the small molecule oral immunomodulator EC-18 resulted in a reduction in both the...

www.onclive.com

Comments / 0

Comments / 0